N/A
Completed N=106
'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'
Source: ClinicalTrials.gov NCT03088917 ↗Enrolled (actual)
106
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcomePrimary: Liver Fibrosis Stage — 3; 1; 1 Participants
Summary
Objective:
To coordinate active tracing of chronic hepatitis C patients lost to follow-up to inform them about there disease severity and treatment options.
Study design: This is a prospective cohort study, which will start as a pilot study in the Radboudumc Population: lost to follow-up chronic hepatitis C patients in the region Nijmegen. This so-called lost population consists of all patients, that in the past have been identified at the Radboudumc but who are currently lost to or have been withdrawn from follow-up. The time-span of interest will be 2000-2015. We estimate that this project will retrace 100 lost patients through this search.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Liver Fibrosis Stage |
3; 1; 1 | — |
| SECONDARY Reasons for Loss to Follow-up |
2; 2; 5; 1 | — |
| SECONDARY Genotype Distribution |
2; 2; 1 | — |
| SECONDARY Fibrosis Progression |
2; 1 | — |
| SECONDARY Treatment Outcome |
2; 2; 1 | — |
Eligibility Criteria
Inclusion Criteria
- ever diagnosed with hepatitis C, lost to follow-up
Exclusion Criteria
- none
Data sourced from ClinicalTrials.gov (NCT03088917). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.